A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

July 19, 2023

Study Completion Date

December 18, 2026

Conditions
Psoriasis
Interventions
DRUG

Guselkumab

Participants will receive a weight-based dose of guselkumab subcutaneously.

DRUG

Placebo for guselkumab

Participants will receive a weight-based dose of placebo for guselkumab subcutaneously.

DRUG

Etanercept

Participants will receive a weight-based dose of etanercept (up to 50 mg) subcutaneously.

Trial Locations (39)

1036

Obudai Egeszsegugyi Centrum Kft, Budapest

1200

Cliniques Universitaires Saint Luc, Brussels

2065

Royal North Shore Hospital, St Leonards

3128

Eastern Health Research, Box Hill

3526

Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz, Miskolc

4000

Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman, Liège

4032

Debreceni Egyetem, Debrecen

4102

Veracity Clinical Research, Woolloongabba

6720

Szegedi Tudomanyegyetem, Szeged

9000

Universitair Ziekenhuis Gent, Ghent

10003

Mt. Sinai School of Medicine, New York

24105

Universitatsklinikum Schleswig Holstein Kiel, Kiel

31217

Dermatologic Surgery Specialists, Macon

35128

Azienda Ospedaliera di Padova, Padua

40138

Azienda Ospedaliera Policlinico S. Orsola-Malpighi, Bologna

42123

Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia

45324

Wright State Physicians Health Center, Dayton

53127

Universitatsklinikum Bonn, Bonn

56242

Company for Medical Study & Service Selters, Selters

60008

Arlington Dermatology, Rolling Meadows

60026

Ospedali Riuniti Di Ancona, Ancona

60590

Universitatsklinikum Frankfurt, Frankfurt

60611

Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's Hospital, Chicago

70178

Hautarztpraxis Dr. Leitz & Kollegen, Stuttgart

78723

Dell Children's Medical Center of Central Texas, Austin

89129

Praxis Dr. med. Beate Schwarz - Germany, Langenau

92123

University of California, San Diego, San Diego

94306

Stanford University, Palo Alto

08520-2505

Windsor Dermatology, East Windsor

76011-3800

Arlington Center for Dermatology, Arlington

T2G 1B1

Kirk Barber Reseach Inc., Calgary

T2J 7E1

Dermatology Research Institute Inc, Calgary

V5Z 4E8

Skin Care Centre, Vancouver

01307

Universitatsklinikum Carl Gustav Carcus Dresden, Dresden

09124

AOU di Cagliari, Cagliari

6525 GA

Radboud University Medical Center, Nijmegen

90-265

Dermed Centrum Medyczne Sp z o o, Lodz

03-924

Szpital Dzieciecy im. prof. dr. med. Jana Bogdanowicza w Warszawie, Warsaw

50 556

Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY